Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 1,925 shares at $365.00 ($683K) on 2021-06-28, disclosed to the SEC on 2021-06-30.
Seasonal sale ($683k) by CMO, Hematology — this insider has traded BGNE in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $365.00 | 425 | $155K | 22.7% |
| 2 | $347.63 | 300 | $104K | 15.3% |
| 3 | $349.22 | 100 | $35K | 5.1% |
| 4 | $351.06 | 400 | $140K | 20.6% |
| 5 | $352.95 | 200 | $71K | 10.3% |
| 6 | $355.26 | 300 |
| $107K |
| 15.6% |
| 7 | $356.98 | 200 | $71K | 10.4% |
| Total | $354.97 avg | 1,925 | $683K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |